Compass Therapeutics Inc

NASDAQ:CMPX  
2.30
+0.08 (+3.60%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Compass Therapeutics Inc Stock, NASDAQ:CMPX

80 Guest Street, Suite 601, Boston, Massachusetts 02135
United States of America
Phone: +1.617.500.8099
Number of Employees: 24

Description

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel bispecific targeting PD-1 and PD-L1, and a portfolio of bispecific and monoclonal antibodies at various stages of pre-clinical development. The company was founded by Thomas J. Schuetz on March 20, 2018 and is headquartered in Boston, MA.